These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8642986)

  • 21. Vitamin E in the treatment of tardive dyskinesia: a replication study.
    Lam LC; Chiu HF; Hung SF
    J Nerv Ment Dis; 1994 Feb; 182(2):113-4. PubMed ID: 8308529
    [No Abstract]   [Full Text] [Related]  

  • 22. Nutritional treatment of tardive dyskinesia.
    Dommisse J
    Am J Psychiatry; 1991 Feb; 148(2):279. PubMed ID: 1987837
    [No Abstract]   [Full Text] [Related]  

  • 23. Tardive dyskinesia revisited.
    Russo DT; Bunch CL
    Am J Health Syst Pharm; 1995 Oct; 52(19):2137-8. PubMed ID: 8535951
    [No Abstract]   [Full Text] [Related]  

  • 24. Vitamin E in the treatment of tardive dyskinesia.
    Boomershine KH; Shelton PS; Boomershine JE
    Ann Pharmacother; 1999 Nov; 33(11):1195-202. PubMed ID: 10573320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The treatment of tardive dyskinesia and tardive dystonia.
    Simpson GM
    J Clin Psychiatry; 2000; 61 Suppl 4():39-44. PubMed ID: 10739330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of vitamin E treatment on tardive dyskinesia and blood superoxide dismutase: a double-blind placebo-controlled trial.
    Zhang XY; Zhou DF; Cao LY; Xu CQ; Chen DC; Wu GY
    J Clin Psychopharmacol; 2004 Feb; 24(1):83-6. PubMed ID: 14709952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia.
    Lohr JB; Caligiuri MP
    J Clin Psychiatry; 1996 Apr; 57(4):167-73. PubMed ID: 8601552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systematic review of cholinergic drugs for neuroleptic-induced tardive dyskinesia: a meta-analysis of randomized controlled trials.
    Tammenmaa IA; Sailas E; McGrath JJ; Soares-Weiser K; Wahlbeck K
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Nov; 28(7):1099-107. PubMed ID: 15610922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholinergic medication for neuroleptic-induced tardive dyskinesia.
    Tammenmaa IA; McGrath JJ; Sailas E; Soares-Weiser K
    Cochrane Database Syst Rev; 2002; (3):CD000207. PubMed ID: 12137608
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does vitamin E prevent tardive dyskinesia?
    Gattaz WF
    Biol Psychiatry; 1995 Jun; 37(12):896-7. PubMed ID: 7548466
    [No Abstract]   [Full Text] [Related]  

  • 31. Benzodiazepines for neuroleptic-induced tardive dyskinesia.
    Bhoopathi PS; Soares-Weiser K
    Cochrane Database Syst Rev; 2006 Jul; (3):CD000205. PubMed ID: 16855954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vitamin E in the treatment of tardive dyskinesia.
    Akhtar S; Jajor TR; Kumar S
    J Postgrad Med; 1993; 39(3):124-6. PubMed ID: 7914238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-dose pyridoxine in tardive dyskinesia.
    DeVeaugh-Geiss J; Manion L
    J Clin Psychiatry; 1978 Jun; 39(6):573-5. PubMed ID: 350860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Vitamin E is ineffective in treatment of late dyskinesias].
    Bridler R
    Praxis (Bern 1994); 2001 May; 90(18):809-10. PubMed ID: 11392285
    [No Abstract]   [Full Text] [Related]  

  • 35. Clonazepam treatment of tardive dyskinesia: a practical GABAmimetic strategy.
    Thaker GK; Nguyen JA; Strauss ME; Jacobson R; Kaup BA; Tamminga CA
    Am J Psychiatry; 1990 Apr; 147(4):445-51. PubMed ID: 1969244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxiperomide in tardive dyskinesia.
    Casey DE; Gerlach J
    J Neurol Neurosurg Psychiatry; 1980 Mar; 43(3):264-7. PubMed ID: 7373324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Partial reversal of the iminodipropionitrile-induced hyperkinetic syndrome in rats by alpha-tocopherol (vitamin E).
    Lohr JB; Cadet JL; Wyatt RJ; Freed WJ
    Neuropsychopharmacology; 1988 Dec; 1(4):305-9. PubMed ID: 3251508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reliability of an instrumental assessment of tardive dyskinesia: results from VA Cooperative Study #394.
    Caligiuri MP; Lohr JB; Rotrosen J; Adler L; Lavori P; Edson R; Tracy K
    Psychopharmacology (Berl); 1997 Jul; 132(1):61-6. PubMed ID: 9272760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacologic probes of neurotransmitter systems in tardive dyskinesia: implications for clinical management.
    Nasrallah HA; Dunner FJ; McCalley-Whitters M; Smith RE
    J Clin Psychiatry; 1986 Feb; 47(2):56-9. PubMed ID: 3003037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-neuroleptic catecholaminergic drugs for neuroleptic-induced tardive dyskinesia.
    El-Sayeh HG; Lyra da Silva JP; Rathbone J; Soares-Weiser K
    Cochrane Database Syst Rev; 2006 Jan; (1):CD000458. PubMed ID: 16437424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.